Novel Product for the Management of Coronary Ruptures Happening during Percutaneous Coronary Interventions
- PMID: 33628517
- PMCID: PMC7892221
- DOI: 10.1155/2021/6688338
Novel Product for the Management of Coronary Ruptures Happening during Percutaneous Coronary Interventions
Abstract
Coronary artery perforation during percutaneous coronary interventions is a rare but dreaded complication. One of the treatment methods for this complication is the injection of an obliterating material into the ruptured vessel. We will introduce a novel material named "Spongostan" for embolization with significant advantages over available treatment options.
Copyright © 2021 Arash Hashemi et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
References
-
- Fogarassy G., Apró D., Veress G. Successful sealing of a coronary artery perforation with a mesh-covered stent. The Journal of Invasive Cardiology. 2012;24(4, article E80) - PubMed
-
- Stathopoulos I., Panagopoulos G., Kossidas K., Jimenez M., Garratt K. Guidewire-induced coronary artery perforation and tamponade during PCI: in-hospital outcomes and impact on long-term survival. The Journal of Invasive Cardiology. 2014;26(8):371–376. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
